Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM007175-18
Application #
2166269
Study Section
Pharmacology-Toxicology Review Committee (PTR)
Project Start
1982-07-01
Project End
1997-06-30
Budget Start
1994-07-01
Budget End
1995-06-30
Support Year
18
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Bisanz, Jordan E; Spanogiannopoulos, Peter; Pieper, Lindsey M et al. (2018) How to Determine the Role of the Microbiome in Drug Disposition. Drug Metab Dispos 46:1588-1595
Eclov, Rachel J; Kim, Mee J; Smith, Robin et al. (2018) Rare Variants in the ABCG2 Promoter Modulate In Vivo Activity. Drug Metab Dispos 46:636-642
Chang, Matthew T; Penson, Alexander; Desai, Neil B et al. (2018) Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis. Clin Cancer Res 24:1965-1973
Li, M; Seiser, E L; Baldwin, R M et al. (2018) ABC transporter polymorphisms are associated with irinotecan pharmacokinetics and neutropenia. Pharmacogenomics J 18:35-42
Rashkin, Sara R; Chua, Katherina C; Ho, Carol et al. (2018) A Pharmacogenetic Prediction Model of Progression-Free Survival in Breast Cancer using Genome-Wide Genotyping Data from CALGB 40502 (Alliance). Clin Pharmacol Ther :
Dolor, Aaron; Kierstead, Paul; Dai, Zhipeng et al. (2018) Sterol-modified PEG lipids: alteration of the bilayer anchoring moiety has an unexpected effect on liposome circulation. Chem Commun (Camb) 54:11949-11952
Vora, Bianca; Wang, Aolin; Kosti, Idit et al. (2018) Meta-Analysis of Maternal and Fetal Transcriptomic Data Elucidates the Role of Adaptive and Innate Immunity in Preterm Birth. Front Immunol 9:993
Yee, Sook Wah; Brackman, Deanna J; Ennis, Elizabeth A et al. (2018) Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium. Clin Pharmacol Ther 104:803-817
Rolt, Adam; Le, Derek; Hu, Zongyi et al. (2018) Preclinical Pharmacological Development of Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection. J Infect Dis 217:1761-1769
Chan, Rosa; Benet, Leslie Z (2018) Evaluation of the Relevance of DILI Predictive Hypotheses in Early Drug Development: Review of In Vitro Methodologies vs BDDCS Classification. Toxicol Res (Camb) 7:358-370

Showing the most recent 10 out of 193 publications